http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006188481-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08af3b5937b2d448a0d6a2fd920e92d2 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10332 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 |
| filingDate | 2006-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_469f84e0fa92ca0930a52050c5929021 |
| publicationDate | 2006-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2006188481-A1 |
| titleOfInvention | Methods for prophylactically or therapeutically treating an animal for an ocular-related disorder |
| abstract | The invention is directed to a method of prophylactically or therapeutically treating an animal for an ocular-related disorder. The method comprises administering to an eye of the animal an expression vector comprising a nucleic acid sequence encoding an adenoviral-responsive gene product. The expression vector transduces a host cell and the nucleic acid sequence is expressed to produce the adenoviral-responsive gene product to treat prophylactically or therapeutically the ocular-related disorder. The invention also provides a method of reducing or inhibiting angiogenesis or photoreceptor cell loss in an eye. The method comprises administering to the eye an expression vector comprising a nucleic acid sequence encoding an adenoviral-responsive gene product. The expression vector transduces a host cell and the nucleic acid sequence is expressed to produce the adenoviral-responsive gene product thereby reducing or inhibiting angiogenesis or photoreceptor cell loss in the eye. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009202505-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420619-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10272040-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8242093-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9956195-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009100253-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101980668-A |
| priorityDate | 2005-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1428.